Company History

2025
2024
2023
2022
2021
2019
2016
2015
2014
2007
2001
2025
  • Invested in Shizhiyuan Company to enter the human medicine sector
2024
  • Lumpy Skin Disease vaccine launched
  • mRNA vaccine production workshop commenced construction
2023
  • R&D of ASF Vaccine (Vector vaccine)
  • Establishment mRNA Technology Platform and established subsidiary-Shenrui Lian.
2022
  • Diversified products launched
  • PCV vaccine and diagnostic products launched
2021
  • Next-generation Inactivated FMD vaccine launched
  • Developed circular mRNA technology
  • Experimental animal breeding base commenced construction
2019
  • The 1st company listed on the Sci-Tech innovation board (STAR Market) in the animal health industry
2016
  • The company's products won the second prize of National Science and Technology Progress Award
2015
  • Diversified biotechnology platform deployed
2014
  • Lanzhou Branch Established
  • Animal Vaccine Production Base constructed
2007
  • Global 1st Synthetic Peptide Vaccine launched
2001
  • Company Established and R&D Synthetic Peptide vaccine
MSG